Tech Company Financing Transactions
Portal Biotechnologies Funding Round
On 6/19/2026, Portal Biotechnologies raised $9 million in funding from NFX, IA Ventures and Pear VC.
Transaction Overview
Company Name
Announced On
6/19/2026
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
134 Coolidge Ave
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Undisclosed
Website
Email Address
Overview
Portal's mission is to develop a universal cell engineering platform. We believe our technology has both transformative potential for research applications and could democratize cell therapies by broadening their biological potential and improving their accessibility.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Armon Sharei
Chief Operating Officer
Alec Barclay
VP - Bus. Development
Elizabeth Kennedy
VP - Human Resources
Andressa Carroll
VP - R & D
Mathias Pawlak
Browse more venture capital transactions:
Prev: 6/18/2026: Castelion venture capital transaction
Next: 6/19/2026: Turbo Law venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs